Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons.
Brain Res. Bull. 32, 477–486.
15. Emerich D. F., Plone M., Francis J., Frydel B. R., Winn S. R. and Lindner M. D. (1996) Allevation of behavioral deficits in
aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res. 736, 99–110.
16. Farooqui T., Franklin T., Pearl D. K. and Yates A. L. (1997) Ganglioside GM1 enhances induction by nerve growth factor of a
putative dimer of Trk A. J. Neurochem. 68, 2348–2355.
17. Felten D. L., Felten S. Y., Fuller R. W., Romano T. D., Smalstig E. B., Wong D. T. and Clemens J. A. (1992) Chronic dietary
pergolide preserves nigrostriatal neuronal integrity in aged Fischer-344 rats. Neurobiol. Aging 13, 339–351.
18. Fernandez-Ruiz J., De Miguel R., Harnandez M. L., Cebeira M. and Ramos J. A. (1992) Comparisons between brain
dopaminergic neurons of juvenile and aged rats: sex-related differences. Mech. Agng Devl 63, 45–55.
19. Ferrari G., Anderson B. L., Stephens R. M., Kaplan D. R. and Greene L. A. (1995) Prevention of apoptotic neuronal death by
GM1 ganglioside. Involvement of Trk neurotrophin receptors. J. biol. Chem. 270, 3074–3080.
20. Finch C. E. (1993) Neuron atrophy during aging: programmed or sporadic? Trends Neurosci. 16, 104–110.
21. Fong T. G., Neff N. H. and Hadjiconstantinou M. (1995) Systemic administration of GM1 ganglioside increases choline
acetyltransferase activity in the brain of aged rats. Expl Neurol. 132, 157–161.
22. Fong T. G., Neff N. H. and Hadjiconstantinou M. (1995) GM1 and NGF synergism on choline acetyltransferase and choline
uptake in aged brain. Neurobiol. Aging 16, 917–923.
23. Fong T. G., Neff N. H. and Hadjiconstantinou M. (1997) GM1 ganglioside improves spatial learning and memory of aged rats.
Behav. Brain Res. 85, 203–211.
24. Fong T. G., Neff N. H. and Hadjiconstantinou M. (1996) Morphological changes of ChAT- or p75-immunopositive neurons in
the aged rat following treatment with GM1 ganglioside. Soc. Neurosci. Abstr. 22, 742.
25. Ghidoni R., Fiorilli A., Trinchera M., Venerando B., Chigorno V. and Tettamanti G. (1989) Uptake, cell penetration and
metabolic processing of exogenous administered GM1 ganglioside in rat brain. Neurochem. Int. 4, 455–465.
26. Hadjiconstantinou M., Karadsheh N. S., Rattan A. K., Tejwani G. A., Fitkin J. G. and Neff N. H. (1992) GM1 ganglioside
enhances cholinergic parameters in the brain of senescent rats. Neuroscience 46, 681–686.
27. Hadjiconstantinou M. and Neff N. H. (1990) Differential recovery of dopamine synthetic enzymes following MPTP and the
consequences of GM1 ganglioside treatment. Eur. J. Pharmac. 181, 137.
28. Hadjiconstantinou M. and Neff N. H. (1998) GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter
systems. J. Neurochem. 70, 1335–1345.
29. Hadjiconstantinou M. and Neff N. H. (1998) GM1 and the aged brain. In Sphingolipids as Signaling Modulators in the Nervous
System (eds Ledeen R. W., Hakomori S., Schneider J. S., Yates A. J. and Yu R. K.), Vol. 845, pp. 225–231. New York
Academy of Science.
30. Hakomori S.-I. and Igarashi Y. (1993) Gangliosides and glycosphingolipids as modulators of cell growth, adhesion and
transmembrane signaling. Adv. Lipid Res. 25, 147–162.
31. Herbert A. M. and Gerhard G. A. (1997) Behavioral and neurochemical effects of intranigral administration of glial cell linederived neurotrophic factor on aged Fischer 344 rats. J. Pharmac. exp. Ther. 282, 760–768.
32. Himi T., Cao M. and Mori N. (1995) Reduced expression of the molecular markers of dopaminergic neuronal atrophy in the
aging rat brain. J. Geront. 50A, B193–B200.
33. Juorio A. V., Walz W. and Sloley B. D. (1987) Absence of decarboxylation of some aromatic l-amino acids by cultured
astrocytes. Brain Res. 426, 183–186.
34. Kish S. J., Zhong X. H., Hornykiewicz O. and Haycock J. W. (1995) Striatal 3,4-dihydroxyphenylalanine decarboxylase in
aging: disparity between postmortem and positron emission tomography studies? Ann. Neurol. 38, 260–264.
35. Lapchak P. A., Miller P. J. and Jiao S. (1997) Glial cell line-derived neurotrophic factor induces the dopaminergic and
cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats. Neuroscience 77, 745–752.
36. Lapchak P. A., Gash D. M., Collins F., Hilt D., Miller P. J. and Araujo D. M. (1997) Pharmacological activities of glial cell
line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease.
Expl Neurol. 145, 309–321.
37. Li X.-M., Juorio A. V., Paterson I. A., Walz W., Zhu M.-Y. and Boulton A. (1992) Gene expression of aromatic l-amino acid
decarboxylase in cultured rat glial cells. J. Neurochem. 59, 1172–1175.
38. Lindsay R. M., Altar C. A., Cedarbaum J. M., Hyman C. and Wiegand S. J. (1993) The therapeutic potential of neurotrophic
factors in the treatment of Parkinson's disease. Expl Neurol. 124, 103–118.
39. Mason I. (1996) The GDNF receptor: recent progress and unanswered questions. Molec. cell. Neurosci. 8, 112–119.
40. McGeer P. L. and McGeer E. (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine, and GABA in
human controls and patients with Parkinson's disease and Huntington's chorea. J. Neurochem. 27, 65–76.
41. McGeer E. G., Fibiger H. C., McGeer P. L. and Wickson V. (1971) Aging and brain enzymes. Expl Geront. 6, 391–396.
42. Moretti A., Carfagna N. and Trunzo F. (1987) Effect of aging on monoamines and their metabolites in rat brain. Neurochem.
Res. 22, 1035–1039.
43. Morgan D. G. and May P. C. (1990) Age-related changes in synaptic neurochemistry. In Handbook of the Biology of Aging, 3rd
edn (eds Schneider E. L. and Rowe J. W.), pp. 219–254. Academic, New York.
44. Mortimer J. A. (1988) Human motor behavior and aging. Ann. N. Y. Acad. Sci. 515, 54–66.
45. Mutoh T., Tokuda A., Miyadai T., Hamaguchi M. and Fujiki N. (1995) Ganglioside GM1 binds to the Trk protein and regulates
receptor function. Proc. natn. Acad. Sci. U.S.A. 92, 5087–5091.
46. Palmer A. M. and DeKosky S. T. (1993) Monoamine neurons in aging and Alzheimer's disease. J. neural Transm. (Gen. Sect.)
91, 135–159.
47. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
48. Rabin S. J. and Mocchetti I. (1995) GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA.
J. Neurochem. 65, 347–354.
49. Reinhard J. F., Miller D. B. and O'Callaghan J. P. (1988) The neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response
to injury. Neurosci. Lett. 95, 246–251.
50. Ren Q., Duchemin A.-M., Neff N.H. and Hadjiconstantinou M. (1998) GM1 increases the activity of MAP kinase in brain
slices. J. Neurochem., Suppl. 70, S14B.
